{"disease":{"id":"external-genital-warts","name":"external genital warts"},"drugs":{"marketed":[{"drug_id":"podofilox","indication_name":"Anogenital warts (external genital warts and perianal warts)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PODOFILOX","company_name":"","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Topical antiviral","quality_score":60,"revenue":null,"mechanism":"Podofilox induces necrosis of anogenital wart tissue, though the exact mechanism is unknown."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03532776","title":"Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":466,"lead_sponsor_name":"Dermax SA","has_results":true},{"nct_id":"NCT02482428","title":"Efficacy and Tolerability of Topical LFX453 for External Genital Warts","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}